NCT01922128View on ClinicalTrials.gov

Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Nonexudative Age-related Macular Degeneration
Interventions
DRUG

MC-1101, Placebo

One drop 0.5%; MC-1101; One drop 1.0% MC-1101, One drop Placebo

Trial Locations (1)

90701

Sall Eye Center, Artesia

All Listed Sponsors
lead

MacuCLEAR, Inc.

INDUSTRY

NCT01922128 - Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration | Biotech Hunter | Biotech Hunter